Skip to main content
Log in

Classification of drugs for teratogenic risk

  • Special Article
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Friedman JM 1993 Report of the Teratology Society Public Affairs Committee Symposium on FDA classification of drugs. Teratology 48:5–6

    Google Scholar 

  2. Teratology Society Public Affairs Committee 1993 FDA classification of drugs for teratogenic risl. Teratology Society Newsletter 3:4–5

    Google Scholar 

  3. Teratology Society Public Affairs Committee (1994) FDA classification of drugs for teratogenic risk. Teratology 49:446–447

    Google Scholar 

  4. Berglund F, Flodh H, Lundborg P, Prame B, Sannerstedt R (1984) Drug use during pregnancy and breast-feeding. Acta Obstet Gynecol Scand Suppl 126:1–55

    Google Scholar 

  5. Linfo, Drug Information Ltd., Sweden (1993) Classification of medicinal products for use during pregnancy and lactation. The Swedish systems. Linfo, Sweden

    Google Scholar 

  6. Gysling E (1992) Medikamente und Schwangerschaft. Pharma-Kritik 14:65–72

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

G. A., B. A. D., I. K., P. L. and R. S. are members of teratology review panel of LINFO

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alván, G., Danielsson, B.R., Kihlström, I. et al. Classification of drugs for teratogenic risk. Eur J Clin Pharmacol 48, 177–178 (1995). https://doi.org/10.1007/BF00198294

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00198294

Key words

Navigation